Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Murine leukemia virus (MLV) replication monitored with fluorescent proteins.

Katja Sliva1, Otto Erlwein, Alexandra Bittner

  • 1Institute for Biomedical Research, Georg-Speyer-Haus, Paul-Ehrlich-Str, 42-44, 60596 Frankfurt/Main, Germany. schba@pei.de

Virology Journal
|December 22, 2004
PubMed
Summary

Researchers developed fluorescently labeled murine leukemia virus (MLV) to track viral replication in real-time. This advancement aids in optimizing MLV-based gene therapy vectors for cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Stop Codon after the nsp3 Gene of Ross River Virus (RRV) Is Not Essential for Virus Replication in Three Cell Lines Tested, but RRV Replication Is Attenuated in HEK 293T Cells.

Viruses·2024
Same author

TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Allergen-specific immunotherapy and evidence: A European regulatory perspective.

Allergologie select·2023
Same author

Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development.

Pathogens (Basel, Switzerland)·2023
Same author

Chikungunya Vaccine Candidates: Current Landscape and Future Prospects.

Drug design, development and therapy·2022
Same author

A Bivalent Trans-Amplifying RNA Vaccine Candidate Induces Potent Chikungunya and Ross River Virus Specific Immune Responses.

Vaccines·2022

Area of Science:

  • Virology
  • Gene Therapy
  • Molecular Biology

Background:

  • Cancer gene therapy requires tumor-replicating vectors with a bystander effect.
  • Replication-competent murine leukemia virus (MLV) shows therapeutic potential but lacks a cytopathic effect, hindering replication studies.

Purpose of the Study:

  • To develop a method for direct monitoring of MLV replication and cell attachment.
  • To utilize fluorescent labeling to study MLV-based vectors for gene therapy.

Main Methods:

  • Inserted green fluorescent protein (GFP) into the MLV ecotropic envelope protein (Env) for fluorescent labeling.
  • Created recombinant MLVs and split viral genomes, labeling one with GFP-Env and the other with red fluorescent protein (RFP).
  • Used flow cytometry to monitor viral replication, attachment, and recombination events.

Related Experiment Videos

Main Results:

  • Successfully fluorescently labeled MLV, enabling direct monitoring of viral replication and cell attachment via flow cytometry.
  • Generated semi-replicative vectors through co-transfection, allowing visualization of individual genome distribution.
  • Observed recombination events by tracking the distribution of differentially labeled viral genomes.

Conclusions:

  • Fluorescently labeled MLVs serve as effective tools for studying factors influencing viral replication.
  • This technique can optimize MLV-based replication-competent viruses and vectors for enhanced gene therapy applications.